Evaluation of Bone Density Measurement in Type 2 Diabetic Postmenopausal Women with Hypertension and Hyperlipidemia.
- Author:
Emel Kiyak CAGLAYAN
1
;
Yaprak ENGIN-USTUN
;
Nagihan SARI
;
Seyhan KARACAVUS
;
Levent SECKIN
;
Mustafa KARA
Author Information
- Publication Type:Original Article
- Keywords: Bone density; Hyperlipidemias; Postmenopause
- MeSH: Absorptiometry, Photon; Alkaline Phosphatase; Body Mass Index; Bone Density*; Calcium; Cholesterol; Chronic Disease; Fasting; Female; Femur Neck; Glucose; Gravidity; Humans; Hyperlipidemias*; Hypertension*; Osteoporosis; Parity; Postmenopause; Spine
- From:Journal of Menopausal Medicine 2015;21(1):36-40
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVES: The aim of the study was to compare bone mineral density (BMD) in healthy postmenopausal women to BMD in type 2 diabetic hypertensive postmenopausal women with hyperlipidemia. METHODS: Fifty type 2 diabetic and hypertensive postmenopausal women with hyperlipidemia and 51 age and body mass index (BMI) matched healthy postmenopausal women were included. Lumbar spine and femoral neck BMD were noted in both groups. BMD was measured using dual energy X-ray absorptiometry (DXA). Serum alkaline phosphatase (ALP), calcium and phosphorous were also measured. Pearson correlation coefficients were used to establish the relationship between various clinical characteristics. RESULTS: There were no significant differences between two groups in respect to lumbar and vertebral BMD values, age, BMI, gravidity, parity. Serum cholesterol and fasting glucose levels were significantly different between each groups (P = 0.0001, P = 0.002). CONCLUSION: We found that, accompanying chronic diseases such as diabetes, hypertension and hyperlipidemia don't affect the BMD measurements at postmenopausal period. So these postmenopausal women don't have excess risk regarding osteoporosis.
